These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8181851)

  • 21. Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.
    Foekens JA; Schmitt M; van Putten WL; Peters HA; Kramer MD; Jänicke F; Klijn JG
    J Clin Oncol; 1994 Aug; 12(8):1648-58. PubMed ID: 8040677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors.
    Niikura H; Sasano H; Sato S; Yajima A
    Int J Gynecol Pathol; 1997 Jan; 16(1):60-8. PubMed ID: 8986534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical Phenotype of Breast Cancer during 25-Year Follow-up of the Royal Marsden Tamoxifen Prevention Trial.
    Detre SI; Ashley S; Mohammed K; Smith IE; Powles TJ; Dowsett M
    Cancer Prev Res (Phila); 2017 Mar; 10(3):171-176. PubMed ID: 28100469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
    Fischer-Colbrie J; Witt A; Heinzl H; Speiser P; Czerwenka K; Sevelda P; Zeillinger R
    Anticancer Res; 1997; 17(1B):613-9. PubMed ID: 9066588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytosolic concentrations of cathepsin D in 88 infiltrating ductal breast carcinomas having negative estrogen and progesterone receptors. Correlation with other clinical and biological parameters].
    Ruibal A; Arias J; Lapeña G; García Díez S; Tejerina A
    Rev Esp Med Nucl; 2001 Jun; 20(4):332-3. PubMed ID: 11940423
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunohistochemical localisation of aromatase and its correlation with progesterone receptors in ovarian epithelial tumours.
    Kitawaki J; Noguchi T; Yamamoto T; Yokota K; Maeda K; Urabe M; Honjo H
    Anticancer Res; 1996; 16(1):91-7. PubMed ID: 8615676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients.
    Fritz P; Tuczek HV; Offinger B; Schwarzmann P; Schieszl S; Wu X; Kleine B; Blödorn J; Multhaupt H
    Prog Histochem Cytochem; 1992; 26(1-4):146-58. PubMed ID: 1283015
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma.
    Villena-Heinsen C; Meyberg R; Axt-Fliedner R; Reitnauer K; Reichrath J; Friedrich M
    Anticancer Res; 2002; 22(4):2261-7. PubMed ID: 12174912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-associated biomarker profiles of human breast cancer.
    Eppenberger-Castori S; Moore DH; Thor AD; Edgerton SM; Kueng W; Eppenberger U; Benz CC
    Int J Biochem Cell Biol; 2002 Nov; 34(11):1318-30. PubMed ID: 12200028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas.
    Halperin R; Zehavi S; Dar P; Habler L; Hadas E; Bukovsky I; Schneider D
    Eur J Gynaecol Oncol; 2001; 22(4):292-6. PubMed ID: 11695812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters].
    Ruibal A; Núñez MI; del Río MC; García Díez S; Rodríguez J; Alvarez De Linera JA
    Rev Esp Med Nucl; 2002 Apr; 21(2):109-14. PubMed ID: 11879619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor.
    Scambia G; Catozzi L; Panici PB; Ferrandina G; Coronetta F; Barozzi R; Baiocchi G; Uccelli L; Piffanelli A; Mancuso S
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):71-8. PubMed ID: 8420353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic grades.
    Marsigliante S; Muscella A; Ciardo V; Barker S; Leo G; Baker V; Mottaghi A; Vinson GP; Storelli C
    Cancer Lett; 1993 Dec; 75(3):195-206. PubMed ID: 7906196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors.
    Valerón PF; Chirino R; Vega V; Falcón O; Rivero JF; Torres S; León L; Fernández L; Pestano J; Díaz-Chico B; Díaz-Chico JC
    Int J Cancer; 1997 Apr; 74(2):175-9. PubMed ID: 9133451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
    Ioachim EE; Athanassiadou SE; Kamina S; Carassavoglou K; Agnantis NJ
    Anticancer Res; 1998; 18(3A):1665-70. PubMed ID: 9673387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cathepsin-D, CA125 and epidermal growth factor receptor in imprint smears of ovarian carcinoma.
    Athanassiadou P; Sakellariou V; Michalas S; Petrakakou E; Zerva C; Athanassiades P; Aravantinos D
    Gynecol Obstet Invest; 1997; 43(2):125-30. PubMed ID: 9067721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of oestrogen and progesterone receptors, Ki-67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African population.
    Mbonde MP; Amir H; Akslen LA; Kitinya JN
    East Afr Med J; 2001 Jul; 78(7):360-5. PubMed ID: 11957260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors.
    Cappelletti V; Brivio M; Miodini P; Granata G; Coradini D; Di Fronzo G
    Tumour Biol; 1988; 9(4):200-11. PubMed ID: 3420376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma.
    Gasparini G; Boracchi P; Bevilacqua P; Mezzetti M; Pozza F; Weidner N
    Breast Cancer Res Treat; 1994 Jan; 29(1):59-71. PubMed ID: 7912568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.